ETR:CAP Cryptology Asset Group (CAP) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free CAP Stock Alerts €18.24 0.00 (0.00%) (As of 03/2/2021) Add Compare Share Share Today's Range€18.24▼€19.1250-Day Range€18.24▼€18.2452-Week Range€2.08▼€25.55Volume702,504 shsAverage Volume216,837 shsMarket Capitalization$2.53 billionP/E Ratio424.19Dividend Yield1.43%Price TargetN/A Stock AnalysisStock Analysis Get Cryptology Asset Group alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Cryptology Asset Group Stock (ETR:CAP)Cryptology Asset Group p.l.c., an asset manager, invests in crypto assets and companies with blockchain-related business models. It also trades in crypto currencies and tokens, as well as provides strategic advice and consultancy services related to the use of blockchain technology. The company was incorporated in 2018 and is based in Sliema, Malta.Read More CAP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CAP Stock News HeadlinesApril 15, 2024 | msn.comI’m a Certified Accountant — Don’t Make These 5 Tax Filing Mistakes on Crypto EarningsApril 14, 2024 | msn.comBitcoin ‘Halving’ Will Deal a $10 Billion Blow to Crypto MinersApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 13, 2024 | finance.yahoo.comReko International Group (CVE:REKO) Will Be Hoping To Turn Its Returns On Capital AroundApril 13, 2024 | msn.comAMINA onboards clients for crypto financial servicesApril 12, 2024 | msn.comCrypto executives put money behind longshot bid to oust Elizabeth WarrenApril 12, 2024 | ft.comHong Kong digital assets exchange warns over viability of city’s new crypto rulesApril 10, 2024 | markets.businessinsider.comCrypto Price Predictions: Where Experts Say These 3 Top Tokens Are Headed in 2025April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 10, 2024 | msn.comThe Rise of Crypto Options and Structured ProductsApril 9, 2024 | msn.comBitcoin Buckles Below $69K as Crypto Bulls Endure $175M LiquidationsApril 5, 2024 | ft.comRipple Labs joins stablecoin rush amid crypto market revivalApril 4, 2024 | msn.comMarc Andreessen, Jeff Vinik Back Crypto Startup Neoclassic CapitalApril 3, 2024 | msn.comFSCA opens the door for crypto assets in personal investment portfoliosApril 3, 2024 | finance.yahoo.comQuant Momentum Trade Is Hot Again in CryptoApril 3, 2024 | finance.yahoo.comTax Tip - Reporting your capital gains as a crypto-asset userApril 3, 2024 | msn.comCrypto: Paradigm Seeks Investment for New Web3 Fund, KBW Initiates Cautious Coverage on Robinhood, and Other UpdatesApril 3, 2024 | tmcnet.comCoinDCX Announces Partnership with Mesh to Advance Digital Asset Transfers in IndiaApril 1, 2024 | msn.comBitcoin's history: A timeline of the top crypto's ups and downs since its '09 inceptionMarch 29, 2024 | thestreet.comBitcoin price can hit $1 million within '12 to 18 months,' per fund CEOMarch 29, 2024 | bloomberg.comSBF’s Sentence and Capital Markets Signal a New Era for CryptoMarch 28, 2024 | msn.comFloki Rallies 15% As Traders Expect It To Outperform Doge, Market Cap Surges By $2B In A MonthMarch 28, 2024 | msn.comWho is Sam Bankman-Fried, the onetime crypto mogul sentenced to 25 years in prison?March 28, 2024 | msn.comUnited States Treasury’s tokenized assets hit over $1 billionMarch 28, 2024 | thestreet.comAfter Bitcoin, Ethereum, analysts reveal crypto poised for 'insane run'March 28, 2024 | ft.comCrypto group Copper launches review after ‘embarrassing’ sushi partyMarch 27, 2024 | forbes.comThe Rise Of Crypto’s Billion Dollar ZombiesSee More Headlines Receive CAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryptology Asset Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorUtilities Industry Utilities - Independent Power Producers Sub-IndustryN/A Current SymbolETR:CAP CUSIPN/A CIKN/A Webwww.encavis.com Phone+49-40-3785620FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio424.19 Forward P/E Ratio37.69 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio239.01 Current Ratio1.74 Quick Ratio1.39 Sales & Book Value Annual Sales$293.54 million Price / Sales8.60 Cash Flow€1.05 per share Price / Cash Flow17.37 Book Value€5.44 per share Price / Book3.35Miscellaneous Outstanding Shares138,440,000Free FloatN/AMarket Cap$2.53 billion OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Patrick Lowry CPAM.B.A., CEO & DirectorMr. Edwin ZammitChief Financial OfficerMr. Jefim GewietCOO & DirectorDr. Michael CallejaCompany Sec.Key CompetitorsUniperETR:UN01E.OnFRA:EOANElectricité de FranceEPA:EDFEngieEPA:ENGIRedeia CorporaciónFRA:RE2View All Competitors CAP Stock Analysis - Frequently Asked Questions How have CAP shares performed in 2024? Cryptology Asset Group's stock was trading at €18.24 on January 1st, 2024. Since then, CAP shares have increased by 0.0% and is now trading at €18.24. View the best growth stocks for 2024 here. Is Cryptology Asset Group a good dividend stock? Cryptology Asset Group (ETR:CAP) pays an annual dividend of €0.26 per share and currently has a dividend yield of 1.22%. The dividend payout ratio is 604.65%. Payout ratios above 75% are not desirable because they may not be sustainable. What other stocks do shareholders of Cryptology Asset Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cryptology Asset Group investors own include Dynavax Technologies (DVAX), TJX Companies (TJX), Aeglea BioTherapeutics (AGLE), Aldeyra Therapeutics (ALDX), Applied Materials (AMAT), Ares Capital (ARCC), ASML (ASML), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX) and BorgWarner (BWA). This page (ETR:CAP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryptology Asset Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.